Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Arena Oncology Associates, PC
mi
from
Lake Sucess, NY
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Arena Oncology Associates, PC
mi
from
Lake Sucess, NY
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Mid Ohio Oncology Hematology, Inc.
mi
from
Columbus, OH
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Mid Ohio Oncology Hematology, Inc.
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Kettering Medical Center
mi
from
Kettering, OH
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Kettering Medical Center
mi
from
Kettering, OH
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Cancer Centers of SW OK
mi
from
Lawton, OK
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Cancer Centers of SW OK
mi
from
Lawton, OK
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
University of Pittsburg Medical Center
mi
from
Pittsburg, PA
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
University of Pittsburg Medical Center
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Medical City Dallas-US Oncology
mi
from
Dallas, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Medical City Dallas-US Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology, PA
mi
from
Dallas, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology Laboratories
mi
from
Fort Worth, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology Laboratories
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
University of Texas Medical School in Houston
mi
from
Houston, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology-Plano East
mi
from
Plano, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology-Plano East
mi
from
Plano, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology
mi
from
Round Rock, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology
mi
from
Round Rock, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology - Round Rock
mi
from
Round Rock, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology - Round Rock
mi
from
Round Rock, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
South Texas Oncology and Hematology
mi
from
San Antonio, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
South Texas Oncology and Hematology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Texas Oncology, PA
mi
from
Wichita Falls, TX
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Texas Oncology, PA
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Utah Cancer Specialists
mi
from
Salt Lake City, UT
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Utah Cancer Specialists
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Fairfax-Northern Virginia Hematology Oncology, PC
mi
from
Fairfax, VA
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Fairfax-Northern Virginia Hematology Oncology, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Virginia Cancer Specialist
mi
from
Fairfax, VA
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Virginia Cancer Specialist
mi
from
Fairfax, VA
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/15/2016
Bankstown-Lidcombe Hospital
mi
from
Bankstown,
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/15/2016
Bankstown-Lidcombe Hospital
mi
from
Bankstown,
Click here to add this to my saved trials
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated:  4/15/2016
UCLA
mi
from
Los Angelas, CA
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated: 4/15/2016
UCLA
mi
from
Los Angelas, CA
Click here to add this to my saved trials
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated:  4/15/2016
Georgetown University
mi
from
Washington,
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated: 4/15/2016
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated:  4/15/2016
Temple University
mi
from
Philadelphia, PA
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated: 4/15/2016
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma
Status: Enrolling
Updated:  4/15/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma
Status: Enrolling
Updated: 4/15/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
Status: Enrolling
Updated:  4/15/2016
Duke Primary Care Research Consortium
mi
from
Durham, NC
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
Status: Enrolling
Updated: 4/15/2016
Duke Primary Care Research Consortium
mi
from
Durham, NC
Click here to add this to my saved trials
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Nashville, TN
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation
Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation
Status: Enrolling
Updated:  4/15/2016
Section of Digestive Diseases, Temple Medical Center
mi
from
New Haven, CT
Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation
Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation
Status: Enrolling
Updated: 4/15/2016
Section of Digestive Diseases, Temple Medical Center
mi
from
New Haven, CT
Click here to add this to my saved trials
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Status: Enrolling
Updated:  4/15/2016
Florida Cancer Specialists
mi
from
Sarasota, FL
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Status: Enrolling
Updated: 4/15/2016
Florida Cancer Specialists
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Status: Enrolling
Updated:  4/15/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Status: Enrolling
Updated: 4/15/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Status: Enrolling
Updated:  4/15/2016
Sarah Cannon Research UK
mi
from
London,
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Status: Enrolling
Updated: 4/15/2016
Sarah Cannon Research UK
mi
from
London,
Click here to add this to my saved trials
Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity
Using Facebook to Increase Social Support for Physical Activity: The INSHAPE Study
Status: Enrolling
Updated:  4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity
Using Facebook to Increase Social Support for Physical Activity: The INSHAPE Study
Status: Enrolling
Updated: 4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Electroacupuncture for Xerostomia in Head and Neck Patients
Status: Enrolling
Updated:  4/18/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Electroacupuncture for Xerostomia in Head and Neck Patients
Status: Enrolling
Updated: 4/18/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase I Trial of the Combination of Dasatinib and Lapatinib
Status: Enrolling
Updated:  4/18/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase I Trial of the Combination of Dasatinib and Lapatinib
Status: Enrolling
Updated: 4/18/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase I Trial of the Combination of Dasatinib and Lapatinib
Status: Enrolling
Updated:  4/18/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase I Trial of the Combination of Dasatinib and Lapatinib
Status: Enrolling
Updated: 4/18/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase I Trial of the Combination of Dasatinib and Lapatinib
Status: Enrolling
Updated:  4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase I Trial of the Combination of Dasatinib and Lapatinib
Status: Enrolling
Updated: 4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
A Phase I/II Study of the HDAC Inhibitor LBH-589 in Combination With the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  4/18/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
A Phase I/II Study of the HDAC Inhibitor LBH-589 in Combination With the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 4/18/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
A Phase I/II Study of the HDAC Inhibitor LBH-589 in Combination With the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  4/18/2016
University of Rochester Medical Center
mi
from
Rocherster, NY
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
A Phase I/II Study of the HDAC Inhibitor LBH-589 in Combination With the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 4/18/2016
University of Rochester Medical Center
mi
from
Rocherster, NY
Click here to add this to my saved trials
Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening
Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening
Status: Enrolling
Updated:  4/18/2016
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening
Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening
Status: Enrolling
Updated: 4/18/2016
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Click here to add this to my saved trials
Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer
A Randomized Trial of Pulmonary Rehabilitation in Patients With Moderate to Severe COPD Who Require Lung Resection for Lung Cancer
Status: Enrolling
Updated:  4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer
A Randomized Trial of Pulmonary Rehabilitation in Patients With Moderate to Severe COPD Who Require Lung Resection for Lung Cancer
Status: Enrolling
Updated: 4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
Status: Enrolling
Updated:  4/19/2016
UMDNJ
mi
from
Newark, NJ
Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
Status: Enrolling
Updated: 4/19/2016
UMDNJ
mi
from
Newark, NJ
Click here to add this to my saved trials
Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer
Phase I Study of Concomitant Pemetrexed and CDDP Plus Radiation Therapy in Patients With Locally Advanced or Metastatic Esophageal or Gastroesophageal (GEJ) Carcinomas
Status: Enrolling
Updated:  4/19/2016
University of Arizona Cancer Center
mi
from
Tucson, AZ
Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer
Phase I Study of Concomitant Pemetrexed and CDDP Plus Radiation Therapy in Patients With Locally Advanced or Metastatic Esophageal or Gastroesophageal (GEJ) Carcinomas
Status: Enrolling
Updated: 4/19/2016
University of Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
Phase II Study for Inoperable Non-Metastatic Pancreatic Cancer (Stage IVA) With Neoadjuvant Gemzar, Taxotere and Xeloda (GTX), and Radiation With Gemzar
Status: Enrolling
Updated:  4/19/2016
Columbia University Medical Center
mi
from
New York, NY
Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
Phase II Study for Inoperable Non-Metastatic Pancreatic Cancer (Stage IVA) With Neoadjuvant Gemzar, Taxotere and Xeloda (GTX), and Radiation With Gemzar
Status: Enrolling
Updated: 4/19/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase II, Double-Blinded, Randomized Evaluation of Femara (Letrozole) Versus Placebo for Adjuvant Treatment After Completion of First-Line Chemotherapy for Patients With Optimally Debulked and Chemoresponsive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling
Updated:  4/19/2016
UT MD Anderson Cancer Center
mi
from
Houston, TX
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase II, Double-Blinded, Randomized Evaluation of Femara (Letrozole) Versus Placebo for Adjuvant Treatment After Completion of First-Line Chemotherapy for Patients With Optimally Debulked and Chemoresponsive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling
Updated: 4/19/2016
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  4/20/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 4/20/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
RAD 0902: A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
Status: Enrolling
Updated:  4/20/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
RAD 0902: A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
Status: Enrolling
Updated: 4/20/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials